From ICRA
RPG Life Sciences announced that ICRA has revised the ratings of the Company -Long term loans (Rs 22 crore) - Upgraded to ICRA A- (Stable) from ICRA BBB+(Stable)
Long term, fund based facilities (Rs 40 crore) - Upgraded to ICRA A- (Stable) from ICRA BBB+(Stable)
Short term, non fund based facilities (Rs 25.92 crore) - Upgraded to ICRA A2+ from ICRA A2
Short term, non fund based facilities (Rs 2 crore) - ICRA A2+ assigned
Powered by Capital Market - Live News
